Skip to content

Effect of acupuncture on clinical pregnancy rate in women undergoing IVF-ET

Effects of acupuncture on clinical pregnancy rate in women undergoing IVF-ET: a multicenter randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100045555
Enrollment
Unknown
Registered
2021-04-19
Start date
2021-05-10
Completion date
Unknown
Last updated
2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

In Vitro Fertilization-Embryo Transfer (IVF-ET)

Interventions

Sponsors

Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Female, aged >= 20 and < 40 years; 2. IVF or ICSI, and fresh embryo transfer; 3. Controlled hyperstimulation (COH) using GnRH-A long regimen, GnRH-A short regimen or GnRH antagonist regimen; 4. 1-2 cleavage embryos or 1 blastocyst are to be transplanted; 5. Voluntarily signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Previous implantation failure for more than 3 times; 2. Untreated uterine diseases that clearly affect the shape of the uterine cavity, including(uterine malformation, submucosal fibroids, adenomyosis, endometriosis, etc.). 3. Untreated endometritis, acute pelvic inflammation, mycotic vaginitis, bacterial vaginitis, adnexitis, hydrosalpinx, or other systemic infections; 4. Those who wish to undergo Preimplantation Genetic Diagnosis/ Screening (PGD/PGS) or donor embryo transfer; 5. Chronic diseases associated with adverse pregnancy outcomes, such as hypertension, clinically symptomatic heart disease, diabetes, liver disease, kidney disease, severe anemia, history of venous thrombosis, history of pulmonary embolism or cerebrovascular events, and malignant tumors; 6. Received Chinese medicine treatment aiming to regulate menstruation and promote pregnancy in recent one month, such as acupuncture, Chinese medicine decoction pieces or Chinese patent medicine.

Design outcomes

Primary

MeasureTime frame
Clinical pregnancy rate;

Secondary

MeasureTime frame
Number of retrieved oocytes;Cycle cancellation rate;Fertilization rate;The cleavage rate;Available embryo rate;High quality embryo rate;Embryo implantation rate;Abortion rate;Live birth rate;Anxiety score;

Countries

China

Contacts

Public ContactXu Huangfang

Institute of Acupuncture and Moxibustion,China Academy of Chinese Medical Sciences

huanfang_xu@126.com+86 15711082019

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026